Lymphomatous Meningitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-03-30
Clinical Trial Update: A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis [Phase 1]
The Phase I study of intrathecal rituximab for lymphomatous meningitis has been withdrawn.